Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists.

Autor: Rose O; Impac2t Research, Maximilianstr. 31-33, Münster, Germany. rose@elefantenapo.de., Happe S; Klinik Maria Frieden Telgte, Telgte, Germany., Huchtemann T; Department of Neurology, University of Münster, Münster, Germany., Mönig C; Department of Neurology, University of Münster, Münster, Germany., Ohms M; Klinik für Neurologie mit Klinischer Neurophysiologie, Herz-Jesu-Krankenhaus Hiltrup, Westfalenstr. 109, Münster, Germany., Schwalbe O; Apothekerkammer Westfalen-Lippe, Münster, Germany., Warnecke T; Department of Neurology, University of Münster, Münster, Germany., Erzkamp S; Impac2t Research, Maximilianstr. 31-33, Münster, Germany.
Jazyk: angličtina
Zdroj: International journal of clinical pharmacy [Int J Clin Pharm] 2021 Jun; Vol. 43 (3), pp. 441-448. Date of Electronic Publication: 2021 Apr 23.
DOI: 10.1007/s11096-021-01263-w
Abstrakt: Background Optimizing therapy regimens through collaboration and combination of available resources is a promising approach to improve quality of life for patients with Parkinson's disease (PD). Aim The aim of this project was to enhance patient-oriented therapy and interprofessional collaboration by establishing a regional PD network. Setting The network is located in a rural area in Germany. It covers primary, secondary and tertiary care facilities across professional boundaries. Development Recruitment of PD specialists and patient support groups was done by the local newspaper to spread the word. The network was initially open to all healthcare professionals, who stated a focus or special interest in PD. A working group for medication was founded within the network by asking for interested participants. Problems in the medication process were discussed within the group. As a consequence, therapy recommendations (quickcards) and a specific medication plan were developed and a certified education curriculum for pharmacists was developed. Implementation The network grew to > 150 participants across all disciplines and sectors. Quickcards were adjusted, approved and implemented by the network during interquartile meetings. Certified education was implemented and became a requirement for participating pharmacists. Evaluation The quickcards on medication plan and drug-drug-interactions were approved to be useful and feasible by the network by unanimous assent. Overall satisfaction with certified education was high (mean of 1.4 on a scale between 1 = high and 6 = low). Conclusion A regional interprofessional PD network with pharmacists was established and new standards were established. Future research needs to measure the effects on patient outcomes.
Databáze: MEDLINE
Externí odkaz: